IN THE NEWS
Venture Notes
IQuity, an integrated data-sciences company in Nashville, said it has added to its bench healthtech advisors Ray Guzman and Damian Mingle, both previously with WPC Healthcare, which recently sold to Intermedix. IQuity, led by CEO Chase Spurlock PhD, recently launched a new data analytics platform.
Machine Learning Platform Can Accurately Predict Onset of MS, Maker Says
IQuity, a data analytics company, announced the launch of an analytics platform that uses machine learning to predict, identify, and monitor chronic disease within large populations of patients, including multiple sclerosis (MS). The platform was validated using a pilot study that assessed the healthcare claims of 20 million people in New York, which encompassed four billion data points. IQuity focused on using these data to predict the onset of MS.
New Analytics Platform Predicts and Monitors Chronic Autoimmune Conditions
IQuity, a Nashville-based data analytics company that specializes in predicting, detecting and monitoring chronic disease, today announced the launch of a revolutionary data mining and analytics platform that will predict and monitor chronic diseases within large populations.
BLOG POSTS
OUR ABSTRACTS
OUR PUBLICATIONS
RECENT PODCASTS
WEBINARS
Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.
